iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
28 employees · est. 2017 · Geneve, Switzerland
Vor Bio
Vor Bio's vision is to cure blood cancers through cell and genome engineering.
110 employees · est. 2016 · Cambridge, United States
Vor Bio is the older company (2017 vs 2016); Vor Bio is the larger of the two.
Side-by-Side Comparison
| Metric | iOnctura | Vor Bio |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Geneve, Switzerland | Cambridge, United States |
| Employees | ||
| Employees | 28 | 110 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $118.37M | $267.80M |
| Funding Rounds | ||
| Funding Rounds | 9 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biotech, Cancer Therapy, Drug Development, Clinical-stage, Cancer Treatment, PI3Kδ Inhibitor, Autotaxin Inhibitor, Tumor Survival Pathways, Immunotherapy, Precision Medicine, Oncology, Investors, Clinical Trial, Innovation, Targeted Therapy | Biopharma, Genome Engineering, Cell Therapy, Cancer Treatment, Immuno-oncology, Clinical-stage Company, Hematopoietic Stem Cells, Targeted Therapies, Selective Targeting, Therapy Development, Immunotherapies, Bi-specific Antibodies, CAR-T Therapy, Toxicity Management, Cancer Research |
| Website | ||
| Website | ionctura.com | vorbio.com |
About iOnctura
iOnctura is a Swiss-based biopharmaceutical company founded in 2017. The company is dedicated to developing precision small molecules to combat neglected and hard-to-treat cancers. Their innovative treatments, including roginolisib and cambritaxestat, have entered mid-stage clinical development, off...
About Vor Bio
Vor Bio is a biotechnology startup founded in 2016 with a vision to cure blood cancers through cell and genome engineering. The company's slogan, "Vor Bio's vision is to cure blood cancers through cell and genome engineering," encapsulates its ambitious goal. Vor Bio is a clinical-stage company base...
We will tell you when either one moves
BounceWatch watches iOnctura and Vor Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at iOnctura and Vor Bio — by email.
Frequently Asked Questions
Compare iOnctura with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at iOnctura on 11 Sep 2024, and Vor Bio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.